Skip to main content

and
  1. Article

    Open Access

    Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study

    SARS-CoV-2 infections are suspected to trigger the coagulation system through various pathways leading to a high incidence of thromboembolic complications, hypercoagulation and impaired fibrinolytic capacity w...

    Lars Heubner, Marvin Greiner, Oliver Vicent, Jan Beyer-Westendorf in Thrombosis Journal (2022)

  2. No Access

    Article

    Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function

    Mild FXIII deficiency is an under-diagnosed disorder because the carriers of this deficiency are often asymptomatic and reveal a phenotype only under special circumstances like surgery or induced trauma. Mutat...

    Arijit Biswas, Vytautas Ivaskevicius, Anne Thomas, Michael Varvenne in Annals of Hematology (2014)

  3. No Access

    Article

    A common F13A1 intron 1 variant IVS1+12(A) is associated with mild FXIII deficiency in Caucasian population

    Mild factor XIII deficiency is an underdiagnosed coagulation disorder. Considering the large number of coding and non-coding polymorphisms identified in the F13A1 gene, there is a possibility that some of these m...

    Vytautas Ivaskevicius, Arijit Biswas, Anne Thomas, Sophie Lyonga in Annals of Hematology (2013)

  4. No Access

    Article

    Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction

    In patients with ST-elevation myocardial infarction (STEMI), direct intracoronary bolus administration of the glycoprotein (GP) IIb/IIIa receptor antagonist abciximab is associated with a reduction in infarct ...

    Steffen Desch, Annelie Siegemund, Ute Scholz in Clinical Research in Cardiology (2012)